Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-08

Clinical Trial Update: The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the effect of spironolactone on blood pressure in adults with type 2 diabetes and resistant hypertension. The study completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Ib Abildgaard Jacobsen | Conditions: Arterial Hypertension, Hypertension, Resistant to Conventional Therapy | Phase 3 | Status: COMPLETED | Results posted: 2014-05-08